Tretinoin

CAS 302-79-4 6 current records 4 historicalSmall Molecule

Who holds supplier records for Tretinoin? 6 organisations hold a current record for Tretinoin: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Italy (1), Germany (1) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tretinoin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tretinoin

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Tretinoin expires 22 Aug 2038. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tretinoin. Country is the organisation's recorded country, not necessarily the manufacturing site.

India2Italy1Germany1China1Country not recorded for 1
Need Tretinoin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Tretinoin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED HyderabadIN
CEP 2019-124 - Rev 01
Tretinoin
Sept 2026—
CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO., LTD. ChongqingCN
CEP 2020-183 - Rev 01
Tretinoin
Sept 2025—
OLON S.P.A. RodanoIT
CEP 2010-034 - Rev 02
Tretinoin, Type 2
Mar 2025Inspected Mar 2025
Italy
SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH MindenDE
R1-CEP 2009-350 - Rev 01
Tretinoin
Apr 2016—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Tretinoin are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • RANBAXY LABORATORIES LTD
    Inactive DMF 24420 · filed Dec 2010
  • SHANGHAI NO 6 PHARMACEUTICAL FACTORY
    Inactive DMF 7996 · filed Apr 1989
  • DSM NUTRITIONAL PRODUCTS LTD
    Inactive DMF 7734 · filed Oct 1988
  • DISTILLATION PROD INDS DIV EASTMAN KODAK CO
    Inactive DMF 1192 · filed Jun 1968

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (39 listed products contain Tretinoin). The latest listed patent expires 22 Aug 2038. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Tretinoin is a dermatological agent used to treat acne vulgaris and acute promyelocytic leukemia. It is a derivative of vitamin A and works by modulating cell differentiation and proliferation.

Chemical identity

IUPAC name
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
Canonical SMILES
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C
InChIKey
SHGAZHPCJJPHSC-FNTQEFCWSA-N
Synonyms
Retin-A API

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Retinoid
Chemical structure
Retinoids

Therapeutic areas

DermatologyOncology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tretinoin?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Tretinoin: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), OLON SPA (Italy), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (Germany), APIONEX PHARMA PVT LTD (India), CHONGQING HUAPONT PHARMACEUTICAL CO LTD and CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tretinoin Drug Master Files are active?

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 26922), OLON SPA (DMF 7474), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (DMF 3456), APIONEX PHARMA PVT LTD (DMF 44473) and CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 27398). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Tretinoin records mean?

4 organisations have only inactive Type II DMFs for Tretinoin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Tretinoin have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Tretinoin on the EDQM register, including BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad (IN), CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO., LTD. Chongqing (CN), OLON S.P.A. Rodano (IT) and SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Tretinoin?

Yes. The latest patent listed for an approved US product containing Tretinoin expires 22 Aug 2038, across 39 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Tretinoin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tretinoin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.